Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/1/59Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Khan B A | en_US |
| dc.date.accessioned | 2017-01-30T08:15:50Z | - |
| dc.date.available | 2017-01-30T08:15:50Z | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/175152 | - |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/1/59 | - |
| dc.description.abstract | Searle examined the loans involved in the flotation of new shares. This particular case examines a local company which had recently acquired a multinational status and then wished to make a private placement at a substantial premium. The case looks at the role of the regulatory authorities, the mechanisms of capital restructuring, and the implication for shareholders. | en_US |
| dc.publisher | YES | en_US |
| dc.subject | Pharmaceuticals | - |
| dc.subject.classification | Finance | en_US |
| dc.subject.other | Capital structure, pharmaceuticals, valuation, stock issues, government regulations | en_US |
| dc.title | SEARLE PAKISTAN (PRIVATE) LIMITED | en_US |
| dc.type | 02-414-95-1 | en_US |
| dc.location | Case Research Centre | en_US |
| Appears in Collections: | Business Case Studies | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.